Odd question: Is gear transdermal?
- 06-14-2009, 04:39 PM
- 06-14-2009, 07:14 PM
There are ways to convert it to transdermal......but damn that's a waste of gear! I say suck it up and keep pinning....you made a commitment when you started the cycle.
06-14-2009, 07:51 PM
06-14-2009, 07:51 PM
06-14-2009, 07:53 PM
06-14-2009, 07:53 PM
06-15-2009, 07:42 AM
Yes, I saw it prior to being edited. As far as being called a *** for not pinning.........I'm over 40 and have ran MANY a cycle and have pinned myself a TON.
I just want to take th next year (or hell, even the next cycle) OFF from pinning. That's all. For me, I never "get used" to pinning. I am just not a fan.
So, if I rub the stuff into the skin, will it work. Just looking for an answer,not a discussioin of IF I should inject or not. Thank you.
06-15-2009, 09:53 AM
06-15-2009, 10:40 AM
06-15-2009, 06:32 PM
06-16-2009, 07:57 AM
ALL good man. I don't get into internet warfare.
Sarcasm/senses of humor - good stuff in life! I just never met you so it came off a bit abrasive LOL
Take care - nice to meet ya
06-16-2009, 10:57 AM
It's not that wild of a question. I knew a guy who mixed stuff up with DMSO and claimed he was absorbing it. I don't know where he got the ratios or how he was so sure, but either it worked as he claimed, or he wasted a lot of money and smelled like a walking turd for a while!
06-16-2009, 04:23 PM
06-16-2009, 06:26 PM
06-16-2009, 07:06 PM
I have done it in my delts, bi's, tri's, quad, etc with a slin pin. Also sub q on the stomach.
Your obviously not going to want to shoot large amounts like this though. So if you need to get 1cc in, splitting it into 2 spots may be ideal.
What dosage are you shooting for?
06-17-2009, 08:13 AM
WOW.This could prove to be helpful as heck for me.
To answer your question, I am only trying to inejct 1 cc at a time.
The concern I have, as stated above, is if I will actually even hit muscle (or that it falls short and ends up being a subQ inject).
For example, if I am trying to do a tricep inject with a slin pin and it doesn't hit the tricep d/t the shortness of the pin, I am not convinced the gear will be absorbed as well subQ and as a result, not only will I notbe getting the intended amont of gear but my hormones will be less stable (d/t to the diff %'s of gear absorbed that particular inject day).
06-17-2009, 10:12 AM
06-17-2009, 10:31 AM
06-17-2009, 01:25 PM
I can't speak for research, other then my own experience.. On my last t-prop cycle, mid cycle, to play around i started injecting with a slin pin, into the muscle, and a few shots sub Q in the stomach, and i noticed ZERO difference in how i felt, nor results, as shooting IM.
I also had a friend try it from the beginning of his cycle, with test prop, and he had good results too..
NOW i am not saying this is for everyone, but if this guy is having that much issue injecting, and is considering rubbing oil based Test prop onto his skin, then IMO this is a MUCH better solution.
06-17-2009, 04:24 PM
yeah, but well, with prop you really have closer to 3-3.5 day usable life, so it would even out pretty fast, i'd guess within 7-10 days. Most of HRT patients doing this would be starting from nothing, and using a longer ester to begin with like cyp. so it takes a bit longer for cyp to even out doing it subq, closer to a full month.
06-17-2009, 04:25 PM
06-17-2009, 04:37 PM
ah, yeah, I was thinking stable and actually oddly MORE effective. from the studies on HRT it seems that most men needed something around half as much injected subq as im
06-17-2009, 04:45 PM
06-17-2009, 04:52 PM
06-17-2009, 04:56 PM
06-17-2009, 04:58 PM
06-17-2009, 04:59 PM
Interesting none the less though. Sounds intriguing but I dont want to be the guinea pig for it.
Remember why you started.
06-17-2009, 05:02 PM
STABLE TESTOSTERONE LEVELS ACHIEVED
WITH SUBCUTANEOUS TESTOSTERONE
M.B. Greenspan, C.M. Chang
Division of Urology, Department of Surgery, McMaster University,
Hamilton, ON, Canada
Objectives: The preferred technique of androgen replacement
has been intramuscular (IM) testosterone, but wide
variations in testosterone levels are often seen. Subcutaneous
(SC) testosterone injection is a novel approach; however,
its physiological effects are unclear. We therefore investigated
the sustainability of stable testosterone levels using
SC therapy. Patients and methods: Between May and
September 2005, we conducted a small pilot study involving
10 male patients with symptomatic late-onset hypogonadism.
Every patient had been stable on TE 200 mg IM for
41 year. Patients were instructed to self-inject with
testosterone enanthate (TE) 100 mg SC (DELATESTRYL
200 mg/cc, Theramed Corp, Canada) into the anterior
abdomen once weekly. Some patients were down-titrated
to 50 mg based on their total testosterone (T) at 4 weeks.
Informed consent was obtained as SC testosterone administration
is not officially approved by Health Canada. T
levels were measured before and 24 hours after injection
during weeks 1, 2, 3, and 4, and 96 hours after injection
in week 6 and 8. At week 12, PSA, CBC, and T levels
were measured however; the week 12 data are still being
collected. Results: Prior to initiation of SC therapy, T
was 19.14+3.48 nmol/l, hemoglobin 15.8+1.3 g/dl, hematocrit
0.47+0.02, and PSA 1.05+0.65 ng/ml. During
the first 4 weeks, there was a steady increase in
pre-injection T from 19.14+3.48 to 23.89+9.15 nmol/l
(p¼0.1). However, after 8 weeks the post-injection T
(25.77+7.67 nmol/l) remained similar to that of week 1
(27.46+12.91 nmol/l). Patients tolerated this therapy with
no adverse effects. Conclusions: A once-week SC injection
of 50–100 mg of TE appears to achieve sustainable and
stable levels of physiological T. This technique offers
fewer physician visits and the use of smaller quantity of
medication, thus lower costs. However, the long term
clinical and physiological effects of this therapy need further
Al-Futaisi AM, Al-Zakwani IS, Almahrezi AM, Morris D. Subcutaneous administration of testosterone. A pilot study report. Saudi Med J. 2006;27(12):1843-6.
OBJECTIVE: To investigate the effect of low doses of subcutaneous testosterone in hypogonadal men since the intramuscular route, which is the most widely used form of testosterone replacement therapy, is inconvenient to many patients. METHODS: All men with primary and secondary hypogonadism attending the reproductive endocrine clinic at Royal Victoria Hospital, Monteral, Quebec, Canada, were invited to participate in the study. Subjects were enrolled from January 2002 till December 2002. Patients were asked to self-administer weekly low doses of testosterone enanthate using 0.5 ml insulin syringe. RESULTS: A total of 22 patients were enrolled in the study. The mean trough was 14.48 +/- 3.14 nmol/L and peak total testosterone was 21.65 +/- 7.32 nmol/L. For the free testosterone the average trough was 59.94 +/- 20.60 pmol/L and the peak was 85.17 +/- 32.88 pmol/L. All of the patients delivered testosterone with ease and no local reactions were reported. CONCLUSION: Therapy with weekly subcutaneous testosterone produced serum levels that were within the normal range in 100% of patients for both peak and trough levels. This is the first report, which demonstrated the efficacy of delivering weekly testosterone using this cheap, safe, and less painful subcutaneous route
06-17-2009, 05:14 PM
06-24-2009, 02:28 PM